Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2018-1382
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM API Connect 5.0.0.0 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 138079.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM API Connect 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM API Connect(又名APIConnect)是美国IBM公司的一套用于管理API生命周期的集成解决方案。该方案支持创建、运行、管理和保护API和微服务等。 IBM API Connect 5.0.0.0版本至5.0.6.4版本、 5.0.7.0版本至5.0.7.2版本和5.0.8.0版本至5.0.8.1版本中存在跨站脚本漏洞。远程攻击者可利用该漏洞在Web UI中注入任意的JavaScript代码。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IBMAPI Connect 5.0.1.0 -
II. Public POCs for CVE-2018-1382
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2018-1382
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2018-1382

No comments yet


Leave a comment